Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea
Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
Clin Mol Hepatol. 2015;21(4):358-364.   Published online 2015 Dec 24     DOI: https://doi.org/10.3350/cmh.2015.21.4.358
Citations to this article as recorded by Crossref logo
Sofosbuvir and Ribavirin with or Without Pegylated-Interferon in Hepatitis C Virus Genotype-2 or -3 Infections: A Systematic Review and Meta-Analysis
Mohammad Ehsan Bayatpoor, Mohammad Hossein Khosravi, Heidar Sharafi, Mohammad Saeid Rezaee-Zavareh, Bita Behnava, Seyed Moayed Alavian
Archives of Clinical Infectious Diseases.2019;[Epub]     CrossRef
Safety and Efficacy of Sofosbuvir and Daclatasvir for Hepatitis C Virus Infection in Patients with β-Thalassemia Major
Rajiv Mehta, Mayank Kabrawala, Subhash Nandwani, Pankaj Desai, Vishwa Bhayani, Sanjay Patel, Viral Parekh
Journal of Clinical and Experimental Hepatology.2018; 8(1): 3.     CrossRef
Prevalence of NS5B resistance-associated variants in treatment-naïve Asian patients with chronic hepatitis C
Song Yang, Huichun Xing, Shenghu Feng, Wei Ju, Shunai Liu, Xiaomei Wang, Weini Ou, Jun Cheng, Calvin Q. Pan
Archives of Virology.2018; 163(2): 467.     CrossRef
Early development of de novo hepatocellular carcinoma after direct-acting agent therapy: Comparison with pegylated interferon-based therapy in chronic hepatitis C patients
S. H. Yoo, J. H. Kwon, S. W. Nam, H. Y. Kim, C. W. Kim, C. R. You, S. W. Choi, S. H. Cho, J.-Y. Han, D. S. Song, U. I. Chang, J. M. Yang, H. L. Lee, S. W. Lee, N. I. Han, S.-H. Kim, M. J. Song, S. Hwang, P. S. Sung, J. W. Jang, S. H. Bae, J. Y. Choi, S. K
Journal of Viral Hepatitis.2018; 25(10): 1189.     CrossRef
Ginsenoside Rg3 restores hepatitis C virus-induced aberrant mitochondrial dynamics and inhibits virus propagation
Seong-Jun Kim, Jae Young Jang, Eun-Jung Kim, Eun Kyung Cho, Dae-Gyun Ahn, Chonsaeng Kim, Han Seul Park, Soung Won Jeong, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Hong Soo Kim, Boo Sung Kim, Jihyung Lee, Aleem Siddiqui
Hepatology.2017; 66(3): 758.     CrossRef
Efficacy and safety of sofosbuvir-based therapy for chronic hepatitis C infection in “real-life” cohort
Rajiv Mehta, Mayank Kabrawala, Subhash Nandwani, Rini Tekriwal, Payal Nandaniya, Mrunal Shah, Vishwa Bhayani
Indian Journal of Gastroenterology.2016; 35(6): 459.     CrossRef
Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection
Nina Weiler, Stefan Zeuzem, Martin-Walter Welker
World Journal of Gastroenterology.2016; 22(41): 9044.     CrossRef